Fred M. Schwarzer

Biography

Mr. Schwarzer currently serves as executive chair on Amaranth Medical, Inc.’s Board of Directors. He is a founder and managing partner of Charter Life Sciences (CLS), a life science-focused venture capital fund. Prior to his founding CLS, Mr. Schwarzer was chief executive officer and then chairman of Heska (HSKA). During his tenure at Heska, he completed corporate partnerships with two large pharmaceutical companies, completed seven acquisitions and completed Heska’s initial public offering and follow-on public offering. During this time, Heska also obtained its first FDA approval, launched its first products, created its sales and marketing effort, and grew its revenue to approximately $40 million. He began his professional career as an attorney representing technology companies and venture capitalists. In 1985, he was made a partner with Pillsbury, Madison & Sutro (now Pillsbury), and in 1988 he founded the firm of General Counsel Associates (now GCA Law Partners). Mr. Schwarzer holds a JD from the University of California, Berkeley, School of Law and a BA from the University of Michigan.

Research Interest

cardiology